# Geke A.P. Hospers

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/geke-a-p-hospers/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,689 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 63 |
| i10-index | 211 |
| Last Known Institution | University Medical Center Groningen |
| OpenAlex ID | https://openalex.org/A5013384569 |
| ORCID iD | https://orcid.org/0000-0002-3047-7892 |
| Works | 546 |

## Researcher papers

- [Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer](https://scholariq.org/papers/preoperative-chemoradiotherapy-for-esophageal-or-junctional-cancer/)
- [Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial](https://scholariq.org/papers/neoadjuvant-chemoradiotherapy-plus-surgery-versus-surgery-alone-for-oesophageal/)
- [Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial](https://scholariq.org/papers/short-course-radiotherapy-followed-by-chemotherapy-before-total-mesorectal/)
- [Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial](https://scholariq.org/papers/ten-year-outcome-of-neoadjuvant-chemoradiotherapy-plus-surgery-for-esophageal/)
- [Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma](https://scholariq.org/papers/tumor-infiltrating-lymphocyte-therapy-or-ipilimumab-in-advanced-melanoma/)
- [Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial](https://scholariq.org/papers/adjuvant-pembrolizumab-versus-placebo-in-resected-stage-iii-melanoma-eortc-1325/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Colorectal Cancer Surgical Treatments](https://scholariq.org/topics/colorectal-cancer-surgical-treatments/)

## Researcher university

- [University Medical Center Groningen](https://scholariq.org/institutions/university-medical-center-groningen/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.